Peter was formerly Senior Vice President for Discovery Research at GlaxoSmithKline. Most recently he Chaired the Boards of GammaDelta Therapeutics and Adaptate Biotherapeutics, both Abingworth portfolio companies. He has also held the Balfour chair in genetics at Cambridge University and research positions at the Imperial Cancer Research Fund. Peter holds doctorates from Oxford and Bristol Universities and is a Fellow of EMBO, the Academy of Medical Sciences and the Royal Society
